基于MRI的深度学习影像组学列线图鉴别交界性卵巢肿瘤与I期卵巢癌:一项多中心研究
该回顾性多中心研究纳入三个中心279例患者,构建基于T2加权MRI的深度学习影像组学列线图(DLRN),用于术前鉴别交界性卵巢肿瘤与I期上皮性卵巢癌。DLRN在10折交叉验证中最高AUC为0.825±0.082,外部测试集AUC为0.819,显著优于临床模型(AUC=0.708,P=0.047)和原始影像组学模型(AUC=0.670,P=0.015)。
要点
- DLRN在外部测试集鉴别交界性卵巢肿瘤与I期上皮性卵巢癌的AUC为0.819。
- DLRN外部测试集AUC显著优于临床模型(0.708)和原始影像组学模型(0.670)。
- 联合影像组学模型外部测试集AUC为0.778,显著优于原始影像组学模型(0.670)。
核心结论
- DLRN在术前鉴别交界性卵巢肿瘤与I期上皮性卵巢癌方面表现出有前景的性能,可能辅助临床决策。
研究设计与样本
- 回顾性多中心研究,纳入三个中心279例患者,分为训练集207例和外部测试集72例;基于T2加权MRI构建深度学习影像组学列线图,所有模型经10折交叉验证和外部测试验证,以AUC评价预测性能。
诊断标准与关键数值
- DLRN在10折交叉验证中最高AUC为0.825±0.082。
- 外部测试集DLRN的AUC为0.819,临床模型AUC为0.708,原始影像组学模型AUC为0.670,DLRN较临床模型P=0.047、较原始影像组学模型P=0.015。
- 外部测试集联合影像组学模型AUC为0.778,原始影像组学模型AUC为0.670,联合影像组学模型较原始影像组学模型P=0.043。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and validate a deep learning radiomics nomogram (DLRN) based on T2-weighted MRI to distinguish between borderline ovarian tumors (BOTs) and stage I epithelial ovarian cancer (EOC) preoperatively.
MATERIALS AND METHODS: This retrospective multicenter study enrolled 279 patients from three centers, divided into a training set (n = 207) and an external test set (n = 72). The intra- and peritumoral radiomics analysis was employed to develop a combined radiomics model. A deep learning model was constructed based on the largest orthogonal slices of the tumor volume, and a clinical model was constructed using independent clinical predictors. The DLRN was then constructed by integrating deep learning, intra- and peritumoral radiomics, and clinical predictors. For comparison, an original radiomics model based solely on tumor volume (excluding the peritumoral area) was also constructed. All models were validated through 10-fold cross-validation and external testing, and their predictive performance was evaluated by the area under the receiver operating characteristic curve (AUC).
RESULTS: The DLRN demonstrated superior performance across the 10-fold cross-validation, with the highest AUC of 0.825±0.082. On the external test set, the DLRN significantly outperformed the clinical model and the original radiomics model (AUC = 0.819 vs. 0.708 and 0.670, P = 0.047 and 0.015, respectively). Furthermore, the combined radiomics model performed significantly better than the original radiomics model (AUC = 0.778 vs. 0.670, P = 0.043).
CONCLUSION: The DLRN exhibited promising performance in distinguishing BOTs from stage I EOC preoperatively, thus potentially assisting clinical decision-making.
引用
- Wang X, Quan T, Chu X, et al. Deep Learning Radiomics Nomogram Based on MRI for Differentiating between Borderline Ovarian Tumors and Stage I Ovarian Cancer: A Multicenter Study. Acad Radiol. 2025. PMID: 39814661. doi:10.1016/j.acra.2024.12.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。